Ticagrelor (trade name Brilinta, Brilique, and Possia) is a platelet aggregation inhibitor. Ticagrelor is an antagonist of the P2Y12 receptor. Ticagrelor has been approved by US FDA in on July 20, 2011.
Product Name: Ticagrelor
Synonyms: AZD-6140; (1S,2S,3R,5S)-3-(7-((1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino)-5-(propylthio)-3H-(1,2,3)triazolo(4,5-D)pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
CAS Number: 274693-27-5
Molecular Weight:  522.5688
Molecular Formula:  C23H28F2N6O4S
Purity (HPLC): ≥99%
Shipping Conditions: Room temperature.
Storage Conditions: Refrigerated.
Regulatory Statement:  For Research Use Only.